Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Y-mabs Therapeutics, Inc. (YMAB)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Y-mabs Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Y-mabs Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is YMAB. The reporting company's CIK number is 1722964.
The total value of stock buying since 2005 is $15,382,784.
The total value of stock sales since 2005 is $6,641,248.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-05-13||Gad Thomas (President and Chairman)||Sale||6,000||20.61||123,648|
|2019-04-11||Gad Thomas (President and Chairman)||Sale||150,000||25.80||3,870,000|
|2019-04-09||Gad Thomas (President and Chairman)||Sale||100,000||26.48||2,647,600|
|2018-09-25||Juan Moller San Pedro Claus (Chief Executive Officer)||Buy||31,250||16.00||500,000|
|2018-09-25||Tyagi Ashu (Director)||Buy||430,174||16.00||6,882,784|
Insider trading activities including stock purchases, stock sales, and option exercises of YMAB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Y-mabs Therapeutics, Inc. (symbol YMAB, CIK number 1722964) see the Securities and Exchange Commission (SEC) website.